Related Experiment Video
Updated: May 22, 2026
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Rilpivirine and complera: new first-line treatment options.
Summary
New HIV medications Rilpivirine and Complera offer alternatives for initial treatment. They are compared to efavirenz, a long-standing preferred option despite potential central nervous system side effects.
Area of Science:
- Pharmacology
- Virology
- Immunology
Background:
- Recent approvals of Rilpivirine (Edurant) and Complera for initial HIV treatment.
- Complera is a single-pill, once-daily regimen combining Rilpivirine with other antiretrovirals.
- Comparison of these new options with efavirenz (Sustiva) and Atripla.
Discussion:
- Efavirenz has been a preferred first-line antiretroviral therapy (ART) component since 1998.
- DHHS guidelines recommend efavirenz-based regimens for initial ART.
- Efavirenz is known for potency and long-lasting effects but has central nervous system side effects.
Key Insights:
- Rilpivirine and Complera represent advancements in HIV treatment options.
- Understanding the efficacy and side effect profiles of new versus established drugs is crucial.
- Patient-centered care involves considering individual tolerance and treatment history.
Outlook:
- Further research will clarify the long-term benefits and risks of Rilpivirine and Complera.
- Evolving treatment guidelines will incorporate data on newer antiretroviral agents.
- Personalized medicine approaches will guide the selection of optimal HIV therapy regimens.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:29Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
02:33Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...